Navigating Third-Party Risk in the Pharmaceutical and Life Sciences Sector
The pharmaceutical and life sciences sector is confronting an increasingly intricate landscape of regulatory scrutiny, expanding environmental, social, and governance (ESG) obligations, and intensifying geopolitical pressures that are reshaping global…
